TOP STORIES

• BUSINESS Ono to Fight Prof. Honjo’s Lawsuit over Opdivo Royalties
  July 7, 2020

• REGULATORY Japan Govt Likely to Stick to 2020 Off-Year Drug Re-Pricing Plan in Honebuto Paper
  July 6, 2020

• BUSINESS Maviret Shrivels, but AbbVie Japan in “Growth Mode” with Oncology, Immunology Drivers: Chief
  July 3, 2020

• ORGANIZATION COVID-19 Having “Serious Impact” on New Drug Development; JPMA Calls for Strong Systems for Emergencies
  July 2, 2020

• BUSINESS 26 Japan Drug Makers Log 4% Fall in Workforce as Downtrend Continues Unabated: FY2019 Securities Reports
  July 1, 2020

• BUSINESS AnGes Launches Clinical Trial for Coronavirus DNA Vaccine
  July 1, 2020

• REGULATORY Japan Approves Entresto, 4 Other Novartis Meds, Rybelsus, 1st Humira Biosimilar and More
  June 30, 2020

• BUSINESS Novo Japan Chief Sees 100 Billion Yen Target Achievable on Ozempic, Rybelsus
  June 30, 2020

• BUSINESS Pfizer Japan Boosting Biosimilar Sales Structure with Dedicated Unit, Ups Its Quality Pitch
  June 29, 2020

• BUSINESS AstraZeneca in Talks with Daiichi Sankyo, Meiji Group on COVID-19 Vaccine Supplies in Japan
  June 29, 2020

• REGULATORY Japan OK for MSD’s 9-Valent HPV Vaccine Could Be Delayed after Deluge of Comments Hit Proposed Rule Changes
  June 26, 2020

• BUSINESS Sosei, AbbVie Link Arms for Inflammatory and Autoimmune Disease Drugs
  June 26, 2020

• BUSINESS Takeda’s CEO Pay Tops 2 Billion Yen in FY2019; Old Guard Pitch to Send in External Director Rejected
  June 25, 2020

• BUSINESS 7 Authorized Generics in June Listing Target Combined 260 Billion Yen Market; Simultaneous Launches Catching On
  June 24, 2020

• BUSINESS Rohto to Launch Stem Cell Clinical Trial for COVID-19 in August, Eyes Conditional OK
  June 24, 2020

• BUSINESS Ayumi Chief Says Contender Debut Will Add Vigor to Enbrel Biosimilar Space, Sees Govt Fee Incentive as Booster
  June 23, 2020

• REGULATORY MHLW to Hasten Electronic Scrip Rollout to Summer 2022: Health Minister
  June 23, 2020

• REGULATORY Sakigake Status Awarded to GSK’s Next-Gen I/O Therapy, 2 More Drugs; System Possibly Subject to Review Next Time
  June 22, 2020

• BUSINESS Lilly Japan Chief Sees Continued Diabetes Investment as Key to Remaining in Top 10
  June 22, 2020

• ACADEMIA Nobel Laureate Honjo Sues Ono over Opdivo Royalties, Demands 22.6 Billion Yen
  June 22, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 107
• 108
• 109
• 110
• 111
• 112
• 113
• 114
• 115
• …
• Next ›
• 最終 »